Nkarta (NKTX) Stock Price Today, Chart, Quote and News | baraka

N

Nkarta (NKTX)

$000.00 0.00% ($0.00)

Today
Week
Month
Year
5 Year
YTD

baraka

getbaraka.com

About Nkarta (NKTX)

Nkarta, Inc. is a biopharmaceutical company that is focused on the discovery, development and commercialization of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies to treat cancer. Its modular NK cell engineering platform allow... Read more

Open
USD6.96
High
USD7.00
Low
USD6.47
52 Week High
USD16.24
Monthly Return
-19.60%
Revenue
--

Daily Vol.
1.55M
Avg. Daily Vol.
989.63k
Market Cap.
512M
52 Week Low
1.28
Annual Return
59.70%

Stock News

Bristol Myers Squibb stock tumbles on cost-cutting initiative

Bristol Myers Squibb stock tumbles on cost-cutting initiative

Yahoo

Alphabet stock pops off on Q1 earnings beat, cash dividend

Alphabet stock pops off on Q1 earnings beat, cash dividend

Yahoo

H&R Block to Release Fiscal 2024 Third Quarter Results on May 9, 2024

H&R Block to Release Fiscal 2024 Third Quarter Results on May 9, 2024

Yahoo

Cigna to offer Humira rivals with $0 copay at specialty pharmacy

Cigna to offer Humira rivals with $0 copay at specialty pharmacy

Yahoo

Unlock More Stock Analysis & Reports

Access detailed stock analysis from LSEG including analyst price target estimates.

Build Your Long Term Wealth

Build Your Long Term Wealth

A modern investment app with fair pricing.

Top Movers

This list tracks the stocks with the most upwards (top gainers) and downwards (top losers) movement in price from the previous day.

Not sure which stock to invest in?

Not sure which stock to invest in?

Get access to easy in-depth stock analysis and reports from Refinitiv with analyst estimates on share price movements.